Up-regulating galectin-1 in the hepatoma microenvironment by soluble galectin-1 during the cisplatin treatment could facilitate the chemoresistance of cancer cells via inducing autophagy [28]. The gene discussed is LGALS1; the disease is hepatocellular carcinoma.